Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 5/20 | 0.40 |
| ▸ | MAOB | P27338 | 5/20 | 0.40 |
| ▸ | KDM1A | O60341 | 4/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.40 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35975 | 0.83 | SLC18A3 (0.45) | SLC18A3SIGMAR1GAAMAPTCYP2C19 | |
| SCHEMBL29557767 | 0.83 | SLC18A3 (0.45) | SLC18A3SIGMAR1GAAMAPTCYP2C19 | |
| SCHEMBL2013478 | 0.82 | SLC18A3 (0.48) | SLC18A3SIGMAR1GAAMAPTTSHR | |
| SCHEMBL10519427 | 0.79 | SLC18A3 (0.42) | SLC18A3SIGMAR1CYP2C19CYP2D6DRD3 | |
| SCHEMBL11796659 | 0.78 | SLC18A3 (0.42) | SLC18A3SIGMAR1TSHRCYP1A2CYP2D6 | |
| SCHEMBL11796662 | 0.78 | SLC18A3 (0.42) | SLC18A3SIGMAR1TSHRCYP1A2CYP2D6 | |
| Bicarbonate SCHEMBL11313316 | 0.76 | AKR1C3 (0.46) | SLC18A3SIGMAR1GAAMAPTAKR1C3 | |
| SCHEMBL11661537 | 0.75 | SLC18A3 (0.52) | SLC18A3SIGMAR1GAAMAPTTSHR | |
| SCHEMBL41763 | 0.75 | — | — | |
| SCHEMBL2766491 | 0.75 | SLC18A3 (0.52) | SLC18A3SIGMAR1GAAMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5908692-A | Ordered organic monolayers and methods of preparation thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-06-01 | — | — | US | claimed |
| US-20250388841-A1 | WELL PLATE AND CULTURE METHOD | MITSUI CHEMICALS, INC. (JP) | 2025-12-25 | — | — | US | disclosed |
| US-12378218-B2 | Cyclopentane compounds | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2025-08-05 | — | — | US | disclosed |
| WO-2024009636-A1 | WELL PLATE AND CULTURE METHOD | 三井化学株式会社 | 2024-01-11 | — | — | WO | disclosed |
| WO-2023091591-A1 | POLYMER BLENDS HAVING IMPROVED ION CONDUCTIVITY, DEVICES, AND METHODS | The Florida State University Research Foundation, Inc. (US) | 2023-05-25 | — | — | WO | disclosed |
| CN-112424182-B | Cyclopentane compounds | 迪哲(江苏)医药股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| US-20230151211-A1 | Polymer Blends Having Improved Ion Conductivity, Devices, and Methods | NATIONAL SCIENCE FOUNDATION | 2023-05-18 | — | — | US | disclosed |
| EP-3790870-B1 | CYCLOPENTANE COMPOUNDS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2023-04-19 | — | — | EP | disclosed |
| US-20220194922-A1 | CYCLOPENTANE COMPOUNDS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2022-06-23 | — | — | US | disclosed |
| US-11274091-B2 | Cyclopentane compounds | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2022-03-15 | — | — | US | disclosed |
| EP-3790870-A1 | CYCLOPENTANE COMPOUNDS | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD (CN) | 2021-03-17 | — | — | EP | disclosed |
| US-10640587-B2 | Polystyrene sulfonate analogs and methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2020-05-05 | — | — | US | disclosed |
| WO-2019215268-A1 | CYCLOPENTANE COMPOUNDS | ASTRAZENECA AB (SE) | 2019-11-14 | — | — | WO | disclosed |
| US-20180265607-A1 | Polystyrene Sulfonate Analogs and Methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-09-20 | — | — | US | disclosed |
| US-9243098-B2 | Compound, polymer, cross-linked compound of polymer, and optical element including cross-linked compound | CANON KABUSHIKI KAISHA (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20140163175-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2014-06-12 | — | — | US | disclosed |
| WO-2013018817-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | WO | disclosed |
| US-5908692-A | Ordered organic monolayers and methods of preparation thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378218-B2 | Cyclopentane compounds | CYP11B2, CYP11B1, SQLE | SLC18A3 3688/4885SIGMAR1 2033/4885GAA 1157/4885 |
| US-20220194922-A1 | CYCLOPENTANE COMPOUNDS | CYP11B2, CYP11B1, SQLE | SLC18A3 3688/4885SIGMAR1 2033/4885GAA 1157/4885 |
| US-11274091-B2 | Cyclopentane compounds | CYP11B2, CYP11B1, SQLE | SLC18A3 3688/4885SIGMAR1 2033/4885GAA 1157/4885 |
| US-20250388841-A1 | WELL PLATE AND CULTURE METHOD | LCP1, CD14, TLL2 | SLC18A3 4728/4885SIGMAR1 1897/4885GAA 2286/4885 |
| US-20140163175-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | PCLAF, PCNA, SMC2 | SLC18A3 4033/4885SIGMAR1 4399/4885GAA 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.